AI Analytics Report Reveals Drivers of the CBD Craze

According to an analysis performed by Tastewise, an artificial intelligence (AI)-powered food trend analysis company, people are searching for functional benefits in what they eat and drink, and that is why cannabidiol (CBD) has picked traction so quickly among consumers.

Tastewise was founded by a former executive at Google called Alon Chen, together with Eyal Gaon. The company analyzes billions of what they call “data points” taken from social media, home recipes and restaurant menus.

They use the findings of such analyzes to provide valuable insights on the ingredients playing a key role in shaping the food and beverages industry.

In its latest report, Tastewise highlights CBD and other ingredients that are having a monumental role in shaping the food and beverages landscape.

The report reveals that a third of all online conversations around food focus on the functional or health benefits of those foods. This could explain why food ingredients where health claims are made on the packaging attract more attention than those that don’t list any health claims.

Specifically for CBD, the report written by Tastewise indicates that there was a 286 percent increase in the number of people who consumed CBD products in order to improve their gut health.

In the last year, the number of people who wanted CBD products in order to improve their sleep rose by 201 percent, at least according to the data points tracked by the analytics company.

The number of people who discussed cannabidiol (CBD) as a food ingredient that improves the immune system increased by 138 percent from last year while those who wanted it for an energy boost increased by 70 percent over the same period.

It should be noted that most CBD on the market is extracted from industrial hemp, so it isn’t surprising that hemp oil registered a whopping 925 percent increase in the number of mentions by consumers looking to use it as a way to manage stress.

Other ingredients that were highlighted in this report include pea protein which saw a 542 percent rise in mentions as a wellness ingredient and celery whose user engagement statistics increased by 187 percent.

Experts say that this report shows how much pressure the FDA is going to be faced with as it formulates regulations for CBD products. Health claims seem to be integral to the success of this industry, and it would be enlightening to hear what CBD companies like Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) and Hemptown USA suggest as ways to keep the industry growing while making limited claims about the health benefits of this cannabinoid.

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.cbdwire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.cbdwire.com
303.498.7722 Office
Editor@CBDWire.com

Archives

Select A Month

CBDWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722